


一般社団法人 再生因子研究会 Regeneration factor Incorporated Association Japan
Medical Practices • kita-aoyama 3-6-7, Aoyama Palacio Tower Level 11, Japan • 1-10 Employees
Company overview
| Headquarters | kita-aoyama 3-6-7, Aoyama Palacio Tower Level 11, Minato-ku, Tokyo, JP |
| Website | |
| NAICS | 62 |
| Keywords | Medical, Regenerative Medicine, Culture Supernatant, Stem Sell |
| Founded | 2020 |
| Employees | 1-10 |
Key Contact at 一般社団法人 再生因子研究会 Regeneration factor Incorporated Association Japan
Yoshiki Toda
Vice Director
About 一般社団法人 再生因子研究会 Regeneration factor Incorporated Association Japan
We produce and provide patented immortalized mesenchymal stem(IMS) cells. IMS cells are immortalized stem cells generated during regenerative medicine research by Nagoya University in Japan that are semi-permanently young and continue to divide. The bioactive substances in the culture supernatant fluid produced from IMS cells are always uniform, allowing for the production of high-quality preparations. The donors from whom the dental pulp, the source of IMS cells, are Japanese children who have been tested for viruses and confirmed healthy. The collection route is also accurately traced and managed at the medical level. We also provide referrals to clinics in Japan that offer stem cell transfusion surgery and stem cell culture supernatant infusion therapy.
一般社団法人 再生因子研究会 Regeneration factor Incorporated Association Japan revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Practices industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
一般社団法人 再生因子研究会 Regeneration factor Incorporated Association Japan has never raised funding before.
Frequently asked questions
4.8
40,000 users



